1
|
Rashid M, Alasiri A, Al Balwi MA, Alkhaldi A, Alsuhaibani A, Alsultan A, Alharbi T, Alomair L, Almuzzaini B. Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Cancer Panel and Next-Generation Sequencing. Genes (Basel) 2021; 12:genes12091326. [PMID: 34573308 PMCID: PMC8470887 DOI: 10.3390/genes12091326] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2021] [Revised: 08/19/2021] [Accepted: 08/22/2021] [Indexed: 11/16/2022] Open
Abstract
B-lineage acute lymphocytic leukemia (B-ALL) is characterized by different genetic aberrations at a chromosomal and gene level which are very crucial for diagnosis, prognosis and risk assessment of the disease. However, there is still controversial arguments in regard to disease outcomes in specific genetic abnormalities, e.g., 9p-deletion. Moreover, in absence of cytogenetic abnormalities it is difficult to predict B-ALL progression. Here, we use the advantage of Next-generation sequencing (NGS) technology to study the mutation landscape of 12 patients with B-ALL using Comprehensive Cancer Panel (CCP) which covers the most common mutated cancer genes. Our results describe new mutations in CSF3R gene including S661N, S557G, and Q170X which might be associated with disease progression.
Collapse
Affiliation(s)
- Mamoon Rashid
- King Abdullah International Medical Research Center (KAIMRC), Department of Bionformatics, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (M.R.); (L.A.)
| | - Abdulrahman Alasiri
- King Abdullah International Medical Research Center (KAIMRC), Medical Genomics Research Department, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (M.A.A.B.)
| | - Mohammad A. Al Balwi
- King Abdullah International Medical Research Center (KAIMRC), Medical Genomics Research Department, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (M.A.A.B.)
- Pathology and Laboratory Medicine, King Abdul Aziz Medical City, Ministry of National Guard Health Affairs, King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (A.A.)
| | - Aziza Alkhaldi
- Pathology and Laboratory Medicine, King Abdul Aziz Medical City, Ministry of National Guard Health Affairs, King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (A.A.)
| | - Ahmed Alsuhaibani
- Pathology and Laboratory Medicine, King Abdul Aziz Medical City, Ministry of National Guard Health Affairs, King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (A.A.)
| | - Abdulrahman Alsultan
- Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children’s Hospital, Ministry of National Guard Health Affairs, King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (T.A.)
| | - Talal Alharbi
- Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children’s Hospital, Ministry of National Guard Health Affairs, King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (T.A.)
| | - Lamya Alomair
- King Abdullah International Medical Research Center (KAIMRC), Department of Bionformatics, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (M.R.); (L.A.)
| | - Bader Almuzzaini
- King Abdullah International Medical Research Center (KAIMRC), Medical Genomics Research Department, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (M.A.A.B.)
- Pathology and Laboratory Medicine, King Abdul Aziz Medical City, Ministry of National Guard Health Affairs, King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), Riyadh 11426, Saudi Arabia; (A.A.); (A.A.)
- Correspondence:
| |
Collapse
|
2
|
Al-Harbi T, Al-Zahrani M, Al-Balwi M, Al-Hazmi A, Alsuhaibani A, Aljafn N, Alsumari F, Aleshaiwi L, Alsuhibani A, Alqasim O, Ahmad N. Clinical course of myeloproliferative leukaemia virus oncogene (MPL) mutation-associated familial thrombocytosis: a review of 64 paediatric and adult patients. Br J Haematol 2021; 194:893-898. [PMID: 34131895 DOI: 10.1111/bjh.17624] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2021] [Accepted: 05/17/2021] [Indexed: 11/30/2022]
Abstract
Familial thrombocytosis (FT) is a rare hereditary haematological disorder characterised by increased platelet count, usually caused by germ-line mutations in thrombopoietin (THPO), myeloproliferative leukaemia virus oncogene (MPL) or Janus kinase 2 (JAK2) genes, and can be associated with increased risk of thrombosis. We aimed to determine the yield of diagnostic tests, assess treatment received and describe the clinical course of MPL-associated FT. We retrospectively reviewed all paediatric and adult haematology patients diagnosed with MPL-related FT, who were seen in our clinics from March 2013 to February 2021. Of 64 eligible patients, 26 (41%) were aged <14 years, while the remaining 38 (59%) patients were adults. The median (interquartile range) age at diagnosis was 20 (33·5) years. In all, 26 tribes were represented in this cohort of 64 patients, out of which 31 (48%) patients belonged to two tribes. A total of 60 patients (94%) had thrombocytosis on blood count. Additional genetic tests, including myelodysplastic syndrome (MDS) gene panel, Philadelphia gene breakpoint cluster region-Abelson (BCR-ABL) and JAK2, were carried out for 52 patients and only one patient was positive for JAK2 mutation. In all, 21 (33%) patients were prescribed aspirin and seven (11%) were prescribed hydroxyurea. Overall, 63 (98%) patients did not develop any thrombotic or haemorrhagic event. There was no significant association of MPL-mutated FT with thrombosis or haemorrhage.
Collapse
Affiliation(s)
- Talal Al-Harbi
- King Abdullah Specialized Children's Hospital, Riyadh, Saudi Arabia.,King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.,King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Mohsen Al-Zahrani
- King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.,King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.,King Abdulaziz Medical City, Riyadh, Saudi Arabia
| | - Mohammed Al-Balwi
- King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.,King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.,King Abdulaziz Medical City, Riyadh, Saudi Arabia
| | - Aiman Al-Hazmi
- King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.,King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.,King Abdulaziz Medical City, Riyadh, Saudi Arabia
| | - Ahmed Alsuhaibani
- King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.,King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.,King Abdulaziz Medical City, Riyadh, Saudi Arabia
| | - Nahed Aljafn
- King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Fatimah Alsumari
- King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Latefah Aleshaiwi
- King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Alanoud Alsuhibani
- King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Ohoud Alqasim
- King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Naveed Ahmad
- King Abdullah Specialized Children's Hospital, Riyadh, Saudi Arabia.,King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia.,King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| |
Collapse
|
3
|
Wadi-Ramahi S, Alzorkany F, Moftah B, Alsuhaibani A. EP-1579: Practical dosimetrical issues in Intraoperative electron radiation therapy. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32014-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
4
|
Boqari DT, Al Faraj S, Arafah M, Aloudah N, Alkhairy KS, Alsuhaibani A, Alsaad KO. Herb-induced acute bone marrow intoxication and interstitial nephritis superimposing glomerular C1q deposition in a patient with paroxysmal nocturnal hemoglobinuria. Saudi J Kidney Dis Transpl 2015; 26:572-9. [PMID: 26022031 DOI: 10.4103/1319-2442.157384] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Paroxysmal nocturnal hemoglobinuria is a rare disease of the red blood cell membrane that renders it lyzable by the complement system, leading to chronic intravascular hemolysis. Renal hemosiderosis is a well-known complication of intravascular hemolytic anemia and can lead to acute kidney injury and renal failure. The use of herbal medicine is common worldwide. The nephrotoxicity of herbal remedies can take several forms, which include acute kidney injury and acute and chronic interstitial nephritis. In addition, the use of herbal remedies can result in bone marrow toxicity and suppression. C1q nephropathy is an uncommon form of glomerular disease characterized by dominant or co-dominant glomerular immunofluorescence positivity for C1q in the absence of clinical and serological evidence of systemic lupus erythematosus, and has various clinical presentations and outcome. Here, we report a patient of undiagnosed paroxysmal nocturnal hemoglobinuria who consumed herbal medicine of unknown constituents and clinically presented with anemia and acute kidney injury. The pathological findings of bone marrow and renal biopsies that include bone marrow intoxication, severe renal hemosiderosis and acute interstitial nephritis and kidney injury, as well as co-dominant glomerular deposition of C1q, are discussed. In addition, we discuss and hypothesize the possible pathogenesis of glomerular C1q deposition in the setting of paroxysmal nocturnal hemoglobulinuria.
Collapse
Affiliation(s)
| | | | | | | | - Khalid S Alkhairy
- Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City and College of Medicine, King Saud University for Health Sciences, Riyadh, Saudi Arabia
| | | | | |
Collapse
|
5
|
Duclos M, Al-Hamad A, Al-Halabi H, Alsuhaibani A, Kost K, Zeitouni A, Hier M, Shenouda G, Black M. Organ Preservation using HDR Brachytherapy for Locally Advanced Head and Neck Cancers: A Single Center Experience. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|